CapsoVisionCV +6.44%10 PB Ratio is 18.33 as of Jun. 26, 2026, which is 6% above its 10-year median of 17.22. GuruFocus rates CV with a GF Score™ of 10/100. The stock has 1 warning sign investors should review. Among 788 Medical Devices & Instruments companies, CapsoVision ranks worse than 96.07% on this metric.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2026-06-26), CapsoVision's share price is $7.44. CapsoVision's Book Value per Share for the quarter that ended in Mar. 2026 was $0.41. Hence, CapsoVision's PB Ratio of today is 18.33.
The historical rank and industry rank for CapsoVision's PB Ratio or its related term are showing as below:
CV'
s PB Ratio Range Over the Past 10 Years
Min: 10.21 Med: 17.22 Max: 36.18
Current: 18.15
During the past 3 years, CapsoVision's highest PB Ratio was 36.18. The lowest was 10.21. And the median was 17.22.
CV's PB Ratio is ranked worse than 96.07% of 788
companies
in the Medical Devices & Instruments industry
Industry Median: 2.02
vs CV: 18.15
During the past 12 months, CapsoVision's average Book Value Per Share Growth Rate was 110.40% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
CapsoVision PB Ratio Related Terms
CapsoVision PB Ratio Historical Data
* Premium members only.
The historical data trend for CapsoVision's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, CapsoVision's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
CapsoVision PB Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, CapsoVision's PB Ratio distribution charts can be found below:
* The bar in red indicates where CapsoVision's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
CapsoVision's PB Ratio for today is calculated as follows:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
CapsoVision (CV) has a PB Ratio of 18.33 as of Jun. 26, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on CapsoVision and its competitors. This is near median its historical median of 17.22. Over the past decade, CapsoVision's PB Ratio has ranged from 10.21 to 36.18. According to the industry distribution chart, CapsoVision ranks #757 out of 788 companies in the Medical Devices & Instruments industry, placing it in the top 96.1%.
Is CapsoVision's PB Ratio too high?
CapsoVision's current PB Ratio of 18.33 is near median its 10-year median of 17.22. Over the past 10 years, this metric has ranged from a low of 10.21 to a high of 36.18. The Medical Devices & Instruments industry median PB Ratio is 2.02. CapsoVision's value of 18.33 is 807.4% above this industry median. Based on the distribution chart, CapsoVision ranks #757 out of 788 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, CapsoVision has a GF Score™ of 10/100, reflecting its overall financial health beyond just this single metric.
How does CapsoVision's PB Ratio compare to SENS and MASS?
According to the Medical Devices & Instruments industry distribution chart, CapsoVision ranks #757 out of 788 companies for PB Ratio. This places CapsoVision in the lower half of its industry. The industry median PB Ratio is 2.02. CapsoVision's value of 18.33 is 807.4% above this benchmark. Historically, CapsoVision's own PB Ratio has ranged from 10.21 to 36.18 over the past decade. While the company's 10-year median is 17.22 vs. the industry median of 2.02, CapsoVision has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Medical Devices & Instruments company?
The median PB Ratio among Medical Devices & Instruments companies is 2.02, based on 788 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. CapsoVision's current PB Ratio of 18.33 is 807.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on CapsoVision and its competitors. For the Medical Devices & Instruments industry, the median PB Ratio is 2.02 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. CapsoVision's current PB Ratio is 18.33, which is near median its own 10-year median of 17.22. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CapsoVision stock overvalued right now?
CapsoVision (CV) has a current PB Ratio of 18.33. The current PB Ratio is 18.33, which is near median its 10-year median of 17.22 and 807.4% above the Medical Devices & Instruments industry median of 2.02. CapsoVision's overall GF Score™ is 10/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For CapsoVision (CV), the current PB Ratio is 18.33 as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
CapsoVision Inc is a commercial-stage medical technology enterprise that innovates, manufactures, and markets endoscopic video imaging devices focused on internal imaging of the gastrointestinal (GI) system. The company's core technology platform is an orally ingestible capsule including multiple cameras facilitating 360-degree imaging, light-emitting diodes for measurement, onboard memory storage, and battery life permitting recording and onboard storage of video images. CapsoVision's products consist of the on-market CapsoCam Plus, directed at the small intestines, and the in-development CapsoColon 3D, directed at the large intestines. Geographically, the company generates the majority of its revenue from the United States.
10GF Score
Get the complete analysis for CV
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CV has been successfully added to your 
